COVID-19：与佳能和俄罗斯R-Pharm建立合资企业：销售诊断成像设备
新型冠状病毒肺炎（COVID-19）：新冠肺炎（COVID-19）：COVID-19：
佳能医疗系统：
我们已经与R-Pharm达成协议，将在俄罗斯和独联体地区建立一家合资企业，负责设备销售和服务维护。
R-Pharm Holding，LLC：
俄罗斯医疗保健巨头/ R-Pharm Holding，LLC（总部：俄罗斯莫斯科，R-Pharm）在俄罗斯/独联体的9个国家/地区销售佳能医疗图像诊断设备。
将来，我们将在获得所有必要的监管许可后成立合资公司。
https://jp.medical.canon/News/PressRelease/Detail/58516-834
R-Pharm partners with a leading Japanese medtech manufacturer Canon Medical Systems
R-Pharm Holding, LLC (Headquarters: Moscow, Russia; Chairman: Alexey Repik, hereinafter R-Pharm) and
Canon Medical Systems Corporation (Headquarters: Otawara, Tochigi Prefecture, Japan; President and CEO: Toshio Takiguchi, hereinafter Canon Medical)
have agreed to establish a joint venture for sales and maintenance of diagnostic imaging equipment, manufactured by Canon Medical, in nine CIS member states, including Russia.
The consummation of the joint venture will occur when all the necessary regulatory approvals are obtained.
On June 29th, 2019, at G20 Osaka Summit in front of the heads of State of both Russia and Japan, R-Pharm and Canon Medical
agreed to establish a framework for a strategic partnership in the territory of the Russian Federation.
The agreement that was struck back then covered plans of future cooperation in sales and maintenance as well as localization of Canon Medical’ diagnostic imaging equipment manufacturing.
Establishment of a joint venture has been proceeding since then. R-Pharm and Canon Medical will continue to strive to realize local manufacturing.
http://www.r-pharm.com/en/press-center/news/471
Releases | Mitsui to Participate in the Russian Pharmaceutical Company R-Pharm – MITSUI & CO., LTD.
https://www.mitsui.com/jp/en/release/2017/1223296_10832.html